支气管扩张
痰
医学
肺
胃肠病学
内科学
病理
肺结核
作者
Jayanth Kumar Narayana,S Aliberti,M Mac Aogáin,T K Jaggi,Nur A’tikah Binte Mohamed Ali,I Fransiskus Xaverius,Francesco Amati,A Gramegna,K Tsaneva-Atanasova,F Blasi,S H Chotirmall
标识
DOI:10.1183/13993003.congress-2022.1646
摘要
Introduction: Emerging work supports the existence of a microbial 9gut-lung9 axis which remains unexplored in bronchiectasis. Methods: Prospective and concurrent sampling of sputum (lung) and stool (gut) in a bronchiectasis cohort (n=57) was performed and subjected to bacteriome (16S rRNA) and mycobiome (18S ITS) assessment. Shotgun metagenomics was performed in a subset (n=15). Data from lung and gut compartments were integrated by weighted similarity network fusion (wSNF) followed by spectral clustering and co-occurrence analysis to assess clinically relevant 9gut-lung9 networks. Results: We report the first description of a 9gut-lung9 axis in bronchiectasis. Microbial communities demonstrate greater fungal overlap but reduced bacterial diversity between the lung and gut, respectively. Multi-biome integration followed by clustering reveals a 9high-risk9 patient group characterised by severe clinical and radiological bronchiectasis including increased exacerbations. These patients exhibit enhanced 9gut-lung9 microbial interactions and significant increases in airway Pseudomonas accompanied by gastrointestinal Bacteroides and Saccharomyces. Profiles of the 9low-risk9 group were characterized by oral commensals. Conclusion: A dysregulated 9gut-lung9 axis associates with poorer clinical outcome in bronchiectasis. Immunomodulation of the 9gut-lung9 axis in bronchiectasis warrants further assessment. Funding: Singapore Ministry of Health9s National Medical Research Council under its Clinician-Scientist Individual Research Grant (MOH-000141) (S.H.C) and Clinician Scientist Award (MOH-000710) (S.H.C).
科研通智能强力驱动
Strongly Powered by AbleSci AI